iRhythm Technologies Announces Upcoming Investor Conference Schedule

Author: Evelyn Baker Updated: 05-21-2025 04:47 PM

iRhythm Technologies Ready for Upcoming Investor Engagements

iRhythm Technologies, Inc. (NASDAQ:IRTC), a renowned player in the digital healthcare landscape, is set to engage with investors at several important conferences. The company focuses on developing reliable solutions that help in the detection, prevention, and prediction of diseases, enhancing overall health outcomes.

Confirmed Conferences and Dates

The management team of iRhythm has announced its participation in three key investor conferences:

William Blair Growth Stock Conference

The first event is the William Blair 45th Annual Growth Stock Conference. Scheduled for June 4, the presentation will take place at 2:00 p.m. Central Time (12:00 p.m. Pacific Time). This is an excellent opportunity for investors to learn more about the company’s growth strategies and innovations.

Goldman Sachs Global Healthcare Conference

Following that, iRhythm will present at the prestigious Goldman Sachs 46th Annual Global Healthcare Conference on June 10. The presentation will occur at 2:40 p.m. Eastern Time (11:40 a.m. Pacific Time), where the company will discuss its roadmap and prospects in the rapidly evolving healthcare market.

Truist Securities MedTech Conference

The company will also make an appearance at the Truist Securities MedTech Conference on June 17 at 1:40 p.m. Eastern Time (10:40 a.m. Pacific Time). This event will further highlight iRhythm's innovative approaches in the medical technology space.

Accessing the Live Presentations

Investors and interested parties can access live and archived webcasts of these presentations through the “Events & Presentations” section on the company's investor website. This feature allows stakeholders to stay informed about the latest developments and strategic directions of iRhythm Technologies.

About iRhythm Technologies

iRhythm Technologies, Inc. is a pioneering digital health company that focuses on leveraging advanced technology to create effective solutions for health management. By using wearable biosensors and cloud-based analytics coupled with proprietary algorithms, the company transforms massive amounts of heart data into clinically relevant insights. Their commitment to patient care drives the vision to provide better data, better insights, and ultimately, better health outcomes for everyone.

Contacting iRhythm Technologies

For any inquiries, interested parties can contact:

Investor Contact

Stephanie Zhadkevich, available via email at investors@irhythmtech.com

Media Contact

Kassandra Perry can be reached through email at irhythm@highwirepr.com.

Frequently Asked Questions

What is iRhythm Technologies known for?

iRhythm Technologies is recognized for developing digital healthcare solutions that help detect, predict, and prevent diseases through advanced technology.

Which investor conferences will iRhythm be attending?

The company will participate in the William Blair Growth Stock Conference, Goldman Sachs Global Healthcare Conference, and Truist Securities MedTech Conference.

How can I access the presentations from these conferences?

Live and archived webcasts can be accessed through the “Events & Presentations” section of iRhythm’s investor website.

Who can I contact for investor relations?

For investor inquiries, you can contact Stephanie Zhadkevich at investors@irhythmtech.com.

What type of data does iRhythm analyze?

iRhythm analyzes data from millions of heartbeats using wearable biosensors and proprietary algorithms to provide clinically actionable information.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.